Browsing publications by Dr Nicola Sunter

Newcastle Authors	Title	Year
Rachel Culpin Dr Kim Pearce Dr Nicola Sunter Dr Tryfonia Mainou-Fowler	MicroRNAs in B-cell chronic lymphocytic leukaemia (B-CLL): mature microRNAs of the miR-17-92 cluster predict for treatment free survival (TFS) in patients with B-CLL	2011
Dr Nicola Sunter Professor Graham Jackson Dr Simon Bomken Dr James Allan	A Functional Polymorphism In the CD95 Cell Death Receptor Associated with Prognosis In Acute Promyelocytic Leukemia	2010
Professor Graham Jackson Dr Nicola Sunter Professor Andy Hall Dr Julie Irving Dr James Allan et al.	A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myeloma	2010
Dr Nicola Sunter Professor Andy Hall Dr Tryfonia Mainou-Fowler Professor Graham Jackson Dr James Allan et al.	Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk	2010
Dr Nicola Sunter Dr Ian Cowell Dr Elaine Willmore Gary Watters Professor Caroline Austin et al.	Role of Topoisomerase IIbeta in DNA Damage Response following IR and Etoposide	2010
Dr James Allan Dr Nicola Sunter Professor Andy Hall Dr Christopher Bacon Jonathan Pointon et al.	Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia	2010
Dr James Allan Dr Nicola Sunter Professor Andy Hall Dr Tryfonia Mainou-Fowler Professor Graham Jackson et al.	A Common Genetic Variant in the 3'UTR of IRF4/MUM1 Associates with Risk of Disease and Poor Prognosis in Chronic Lymphocytic Leukaemia	2008
Dr Nicola Sunter Professor Andy Hall Dr Tryfonia Mainou-Fowler Professor Graham Jackson Dr James Allan et al.	A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia	2008
Dr Ian Cowell Dr Nicola Sunter Professor Caroline Austin Emeritus Professor Barbara Durkacz Dr Michael Tilby et al.	γH2AX foci form preferentially in euchromatin after ionising-radiation	2007
Dr Elaine Willmore Dr Nicola Sunter Dr Michael Tilby Professor Graham Jackson Professor Caroline Austin et al.	A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia	2004